APA (7th ed.) Citation

S, P., LR, S., J, S., L, P., G, A., A, L., . . . BMK, B. (2017). Long-term treatment of Cushing's disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial. Endocrine, 57(1), 156. https://doi.org/10.1007/s12020-017-1316-3

Chicago Style (17th ed.) Citation

S, Petersenn, et al. "Long-term Treatment of Cushing's Disease with Pasireotide: 5-year Results from an Open-label Extension Study of a Phase III Trial." Endocrine 57, no. 1 (2017): 156. https://doi.org/10.1007/s12020-017-1316-3.

MLA (9th ed.) Citation

S, Petersenn, et al. "Long-term Treatment of Cushing's Disease with Pasireotide: 5-year Results from an Open-label Extension Study of a Phase III Trial." Endocrine, vol. 57, no. 1, 2017, p. 156, https://doi.org/10.1007/s12020-017-1316-3.